published patents


published patents


research tools


published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Therapy areas
More posts

Ualh har cell line

UALH were generated by transfection of osteocarcinoma cancer U2OS cells with the (ARE-RAD9)6-collagenase-Luciferase-SV40-hygromycin plasmid. UALH […]

Rbl-2h3 rat mast cell line : in vitro degranulation assay for

Rat mast cell line (RBL-2H3) transfected with the cDNAs encoding the three subunits (alpha, beta, gamma) of the human high affinity IgE receptor. The […]

Hek 293 cells expressing human prolactin receptor and lhre-lucifease

This stable clone of HEK 293 cells has stably incorporated the sequence encoding the long isoform of the human prolactin receptor and a […]

Ht29-mtx cells : intestinal model of goblet cells

HT29MTX10-6, HT29MTX10-5 and HT29MTX10-4 cell populations were isolated from the colon cancer cell line by stepwise adaptation to 10-6 M and 10-5 M […]

Tagged leptin receptors hek293t cells

Hek293T cells were transfected with short form human leptin receptors (OBR) tagged individually with either Rluc (pIRESpuro3, Clontech) or YFP […]

Stable human prolactin receptor ba/f3 cell

Ba/F3 cells are mouse pro-B lymphocytes that are dependent on IL-3 for survival/growth. We stably transfeted them with expression vector encoding the […]

Hg5ln cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the (GAL4RE)5-betaGlobin-Luciferase-SV40-Neomycin plasmid. […]

More posts

You might also be interested in


Inserm Transfert

Research tool licensing team